C-NMR and MS). The in vitro antileishmanial potency of the synthesized compounds was evaluated compared to Amphotericin B deoxycholate and miltefosine as lead references. Compounds 2b, 7d and 7e showed perfect IC50 values corresponding to amphotericin B and more patent than miltefosine against L. aethiopica promastigotes.
INTRODUCTION
Leishmaniasis occurs as visceral, cutaneous, mucocutaneous and diffused mucocutaneous leishmaniasis and is caused by Leishmania genus and transmitted by bite of infected female sand fly [1] . Leishmania parasites have two basic life stages: an extracellular motile stage (promastigote) inside an invertebrate host and an intracellular non-motile stage (amastigote) inside a vertebrate host [2] . The common form of leishmaniasis is Cutaneous leishmaniasis (CL) which widely distributed all around the world [3] . Within the last decade, the treatment is limited to a few drugs, such as amphotericin B, miltefosine and paromomycin and far from satisfactory [4] , although a broad array of species can be responsible to cause leishmaniasis, affecting humans and animals [6] [7] [8] [9] [10] [11] . Miltefosine-resistant Leishmania donovani promastigotes also demonstrated modification in sterol biosynthesis and lipid compositions which influences the membrane fluidity and permeability and ultimately may affect drug-membrane interactions [5] . Other possible oral treatments for CL include azole antifungals that show in vitro [12] and in vivo activity against Leishmania [13] [14] [15] [16] [17] [18] [19] [20] . Triazoles antifungals inhibit 14α-lanosterol demethylation, causing accumulation of 14α-methyl sterols blocking the synthesis of ergosterol, the main sterol of Leishmania such as fluconazole, eliminating promastigote and amastigote of Leishmania sp. as well as Trypanosoma cruzi, protozoa phylogenetically related to Leishmania [21] .
In deeps, imidazo triazole moieties have been widely reported in the mainstream as well as in the patent literature [22] [23] [24] [25] [26] , also demonstrated dual activity against leishmania [27, 28] . Therefore, as a part of our effort to use a simple and effective method for the synthesis of bioactive imidazo [1, 2, 4] triazole analogues searching for a new drug candidates for Leishmanial aethiopica promatigote.
EXPERIMENTAL
Melting points were determined in open-glass capillaries using a Griffin melting point apparatus and are all uncorrected. Infrared spectra (IR) were recorded on Perkin Elmer 1430 infrared spectrophotometer.
1 H-NMR and 13 C-NMR spectra were scanned on Jeol-400 MHz NMR-
Method B.
To a solution of 2-amino-5(2-hydroxy phenyl)-1,2,4-triazole carboxylic acid 1b,d (0.01 mol) and chloroacetyl chloride (1.1 g, 0.01 mol) in chloroform and triethylamine as a catalyst. The reaction refluxed for 7 h to complete the reaction (monitored by TLC). After completion of the reaction, mixture was cooled to room temperature and the solid mass was filtered off and recrystallized from ethanol to give compounds 3b,d. [2,1- [1,2-b] [1, 2, 4] 
3-(2-Hydroxyphenyl)-3H-imidazo

2-(2-(2-Hydroxyphenyl)-2-methyl-5-oxo-5,6-dihydro-1H-imidazo
General procedure for synthesis of compounds 4b,d
To a solution of 2-amino-5(2-hydroxy phenyl)-1,2,4-triazole carboxylic acid 1a,d (0.01 mol) and 4-chlorobenzoyl chloride (1.28 mL, 0.01 mol) in chloroform and a catalytic amount of triethylamine as a catalyst. The reaction component was refluxed for 7 hrs to complete the reaction (monitored by TLC). After completion of the reaction, mixture was cooled to room temperature and the solid mass of the compounds was filtered off and recrystallized from ethanol. 
2-(3-(4-
Chlorobenzamido)-5-(2-hydroxyphenyl)-5-methyl-1H-1,
General procedure for synthesis of compounds 5a, 6a
Method A. 2-Amino-5(2-hydroxy phenyl)-1,2,4-triazole carboxylic acid 1a (0.01 mol) was dissolved in 3 mL thionyl chloride and kept for 24 hrs at room temperature. After completion of the reaction, the mixture was poured into petroleum ether drop-wise and the solid mass was filtered off and recrystallized from ethanol into compound 5a.
Method B. An equimolar mixture of 2-amino-5(2-hydroxy phenyl)-1,2,4-triazole carboxylic acid 1a (0.01 mol) and thionyl chloride (1.2 g, 0.01 mol) was dissolved in 3 mL DMF. The reaction mixture was refluxed for 3 hrs (as monitored by TLC). After completion of the reaction, mixture was poured into ice and the solid mass was filtered off and recrystallized from ethanol into compound 6a. 
2-(3-Amino-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-4(5H)-yl
General method for preparation of 7a, c, d, e
An equimolar of 2-amino-5(2-hydroxy phenyl)-1,2,4-triazole carboxylic acid 1a, c, d , e (0.01 mol) and 5 mL Acetic anhydride in presence of few drops of pyridine. The reaction was refluxed for 2-4 hrs (monitored by TLC). After completion of the reaction, the mixture was poured into ice and the solid mass of the compounds was filtered and recrystallized from ethanol. -5-(2-hydroxyphenyl)-5-methyl-1H-1,2,4-triazol-4(5H)-yl)-3-(1H-indol-2-yl) 
2-(3-acetamido-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-4(5H)-yl
2-(3-Acetamido-5-(2-hydroxyphenyl)-1H-1,2,4-triazol-4(5H)-yl)-3-(1H-indol-2-yl
2-(3-Acetamido
RESULT AND DISCUSSION
The starting material amino acid coupled triazoles 1a-e [29] were allowed to react with different reagents such as acid chloride derivatives, thionyl chloride acetic anhydride then a comparative study of the antileishmanial activity was achieved on the synthesized compounds searching for structure-activity relationship information to support the development of new drug candidates for Leishmanial aethiopica promastigotes (Table 1) . The reaction of compounds 1a,b and 1d with chloroacetyl chloride in acetonitrile/water as a solvent and in the presence of potassium carbonate as catalyst (method A) afforded the unexpected products imidazo-1,2,4-triazole 2a,b. The reaction mechanism of formation of the unexpected products 2a,b was suggested to proceed via acetylation of amino group in first step then a preliminary elimination of an acid molecule followed by tautomerization and cyclization, Scheme 1.
Scheme 1
The structures of the synthesized compounds were assigned based on spectral data (IR, 1 H-NMR, 13 C-NMR, MS) and elemental analysis. IR spectra of compounds 2a,b showed new peak owing to the new carbonyl group of imidazole ring located at 1695 and 1713 cm -1 , respectively. 1 H-NMR spectra showed the presence of protons of R 1 where noted singlet signal at 3.99 ppm for CH triazole group in case of compound 2a, also singlet signal at 2.43 ppm for CH 3 group in case of compound 2b. Moreover, showed disappearance of protons of R 2 , CH and COOH groups which noted in starting compound, in addition to the existence of new singlet signal of CH 2 group of imidazole ring at 3.92 and 4.02 ppm corresponding to compound 2a and 2b, respectively.
13 C-NMR spectrum showed the disappearance of signal of carbonyl group of carboxylic acid group and appearance of new carbonyl group of imidazole ring at 170.10 and 186.94 ppm, respectively.
Reaction of compound 1b with chloroacetyl chloride in chloroform in presence of a catalytic amount of triethylamine (method B) afforded the corresponding 5-oxoimidazo-1,2,4-triazolepropanoic acid 3b (Scheme 2). Where IR spectrum of compound 3b illustrated the appearance of new peaks at 1714 cm -1 corresponding to the carbonyl group, 1 H-NMR showed the presence of two CH 3 groups and CH 2 group at 2.55, 3.86 and 4.01 ppm and 13 C-NMR spectrum showed the appearance of two signals of two carbonyl groups at 169.27 and 174.13 ppm. Also, the reaction of compound 1b and 1d with 4-chlorobenzoyl chloride in chloroform in the presence of few drops of triethylamine gave the corresponding N-aryl derivatives 4b and 4d. The IR spectra showed the presence of new peak of carbonyl group of carbonyl acid.
1 H-NMR illustrated increase the protons number due to the phenyl group of chlorobenzoyl chloride. 13 C-NMR spectrum of compound 4b showed appearance of two signals of two carbonyl groups at 179.47 and 198.56 ppmand 173.79 and 180.56 ppm for compound 4d, Scheme 2. N-acetylacetamido-1,2,4-triazol-4(5H)-propanoic acid 7a,c,d ,e Scheme 4. IR spectrum illustrated the appearances of new carbonyl group owing to acetyl group.
1 H-NMR spectrum of compounds 7a,c,d,e showed singlet signals of acetyl group at 2.22, 1.92, 1.87 and 1.92 ppm, respectively.
13 C-NMR of these compounds observed two signals of carbonyl group, one of carboxylic acid and the other for acetyl groups which proven the expected chemical structure.
Scheme 4
In vitro anti leishmanial activity on Leishmanial aethiopica promastigotes
The Alamar blue indicator (oxidation-reduction®) was enhanced to mensuration cytotoxicity of new heterocyclic compounds against the protozoan parasite L.aethiopica by using a quantitative colorimetric method. Alamar blue assay was used to measure the viability of promastigotes and determine the ant leishmanial activity of the synthesized compounds [30] [31] [32] [33] [34] (supporting information). To evaluate the ant leishmanial activity of the synthesized compounds, a final concentration of 1 mg/mL of synthesized compounds dissolvedin DMSO. There are no effects on parasite when the final concentration of DMSO did not exceed 0.1%. Test and standard solutions were diluted to suitable concentrations using fresh complete media. The test compounds were prepared by three-fold serial dilutions (starting from 10 to 0.04 mg/mL)
The test compounds were used in three-fold serial dilutions to evaluate its antileishmanial activity according to Amphotericin B deoxycholate and miltefosine were used as positive controls for comparison. Promastigote type of L. aethiopica was used for the assay. A 100 mL of culture media containing 3x10 6 promastigotes of L. aethiopica were seeded in each well of a 96 well flat bottom plate. Different dilutions of test compounds (10, 3.33, 1.11, 0.37, 0.12, 0.04 mg/mL) were added to the parasites. The assay was done in duplicates. The parasites existed only in wells; media and DMSO were used as negative control. The plates were remained at room temperature (21±1 o C). After 24 h, 10 mL wasadded to each of the wells of Alamar blue (12.5 mg resazurin dissolved in 100 mL of distilled water) [32] . After 48 h, absorbance of the resulting mixture was measured at 540 and 630 nm using a plate reader. Alamar blue works through the conversion of resazurin (7-hydroxy-3H-phenoxazine-3-one-10-oxide), the active ingredient of Alamar blue® (blue and non-fluorescent), to resorufin (pink and highly fluorescent) through reduction reactions of metabolically active cells. There is a proportional relationship between the amount of fluorescence produced and the number of living cells.
All the synthesized compounds had IC 50 better than standard drugs miltefosine and comparative activity to amphotericin B deoxycholate. The lead compound 7d showed more activity than amphotericin B and about 110 folds than miltefosine. Moreover, compounds 2b and 7e showed similar activity to amphotericin Band high activity to miltefosine, which Utility of amino acid coupled 1,2,4
indicates its ant leishmanial activity against L. aethiopica. In deeps, compounds showed low activity corresponding L. aethiopica promastigotes ( Table 2 ). The bar chart (Fig  the tested compound comparing 
In vivo acute toxicity testing
The most active ant leishmanial compounds, (supporting information) [35, treatment with the test compounds. There was no significant difference in the weight of the mice and no death cases were recorded during 3 days of observation post administration of the test compounds ( Table 2 ). The test compounds were well tolerated by the experimental animals orally up to 250 mg/kg. Eleven groups of mice, each group consisting of six male mice (25 g) were used for testing acute toxicity [30] . The mice in each group were fasted overnight and weighed prior to test. The compounds were prepared in suspension form in aqueous vehicle containing 1% gum acacia. Mice in group one to ten were given 25, 50, 100, 20 of the synthesized compounds as a single dose for only one day, while the eleventh group was treated orally with the vehicle gum acacia (control group) at a maximum dose of 1 mL/100 g of body weight. The mortality percentage in each group w test compounds were investigated for their parenteral acute toxicity in groups of six mice each as reported earlier. The compounds, or their vehicle, propylene glycol (control), were given by intraperitoneal injection in doses of 10, 25, 50, 75, 100 mg/kg. The survival percentage was followed up to seven days. indicates its ant leishmanial activity against L. aethiopica. In deeps, compounds 6a, 7a, 7c corresponding to amphotericin B and more patent than miltefosine against ( Table 2 ). The bar chart (Figure 1 ) illustrated the resulted data of the tested compound comparing to reference drugs.
. The test compounds showed the highest antileishmanial activity, compared with the
The most active ant leishmanial compounds, 2b, 7d and 7e were tested for their toxicity in mice 36]. The experimental mice did not have any toxicity signs after treatment with the test compounds. There was no significant difference in the weight of the mice recorded during 3 days of observation post administration of the test compounds ( Table 2 ). The test compounds were well tolerated by the experimental animals orally up to 250 mg/kg. Eleven groups of mice, each group consisting of six male mice (25 re used for testing acute toxicity [30] . The mice in each group were fasted overnight and weighed prior to test. The compounds were prepared in suspension form in aqueous vehicle containing 1% gum acacia. Mice in group one to ten were given 25, 50, 100, 200 and 350 mg/kg of the synthesized compounds as a single dose for only one day, while the eleventh group was treated orally with the vehicle gum acacia (control group) at a maximum dose of 1 mL/100 g of body weight. The mortality percentage in each group was recorded after 24 h. Additionally, the test compounds were investigated for their parenteral acute toxicity in groups of six mice each as reported earlier. The compounds, or their vehicle, propylene glycol (control), were given by ion in doses of 10, 25, 50, 75, 100 mg/kg. The survival percentage was 567 6a, 7a, 7c to amphotericin B and more patent than miltefosine against 1) illustrated the resulted data of
The test compounds showed the highest antileishmanial activity, compared with the were tested for their toxicity in mice The experimental mice did not have any toxicity signs after treatment with the test compounds. There was no significant difference in the weight of the mice recorded during 3 days of observation post administration of the test compounds ( Table 2 ). The test compounds were well tolerated by the experimental animals orally up to 250 mg/kg. Eleven groups of mice, each group consisting of six male mice (25) (26) (27) (28) (29) (30) re used for testing acute toxicity [30] . The mice in each group were fasted overnight and weighed prior to test. The compounds were prepared in suspension form in aqueous vehicle 0 and 350 mg/kg of the synthesized compounds as a single dose for only one day, while the eleventh group was treated orally with the vehicle gum acacia (control group) at a maximum dose of 1 mL/100 g of as recorded after 24 h. Additionally, the test compounds were investigated for their parenteral acute toxicity in groups of six mice each as reported earlier. The compounds, or their vehicle, propylene glycol (control), were given by ion in doses of 10, 25, 50, 75, 100 mg/kg. The survival percentage was
Molecular docking
In the present study, molecular docking was performed to rationalize the obtained biological results. The interactions of the synthesized compounds with the active site of target macromolecules were investigated to study the mode of binding and their orientations and related to their ant leishmanial activity. The binding site of Leishmania major pteridine reductase LmPTR1 (PDB ID: 2BFM) was explored computationally, were carried out using Molecular Operating Environment (MOE Dock 2016) software [37] . The crystal structure of LmPTR1 with the bound TOP (PDB ID: 2BFM) was downloaded from the protein data bank. PTR1 represents a target for the development of improved therapies for infections caused by this protozoan. Target compounds were constructed using the builder interface of the MOE program and all hydrogens were added. Conformational analyses were done through energy minimization using Force Field MMFF94x. The active sites of both proteins were generated using the MOEAlpha Site Finder, and then ligands were docked within this active site using MOE Dock. 
CONCLUSION
The objectives of the present study were to synthesize, characterized and investigate the ant leishmanial activities of some imidazo-1,2,4-triazole moiety serving as more potent dual ant leishmanial agents. The in vitro anti promastigote activity showed that IC 50 value of compounds 2b, 6a, 7a, 7c and 7e better than standard drugs miltefosine and comparative activity to amphotericin B deoxycholate. The superior compound 7d showed more activity than amphotericin B and about 110 folds more active than miltefosine. These findings were supported by the docking for 2b compound, which demonstrated that this compound established hydrogen bonding with some amino acid residues in LmPTR1 active site, which showed good binding profile in addition to some hydrophobic interactions with good scoring results. Toxicity studies for the most active compounds indicated their safety orally and parenterally up to 300 and 100 mg/kg, respectively. In conclusion, compounds 2b, 7d and 7e demonstrated dual activity against leishmania and represent fruitful scaffolds for the development of dual acting ant leishmanial agents.
